0000937556-24-000030.txt : 20240430
0000937556-24-000030.hdr.sgml : 20240430
20240430201111
ACCESSION NUMBER: 0000937556-24-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240426
FILED AS OF DATE: 20240430
DATE AS OF CHANGE: 20240430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REYNOLDS CRAIG B
CENTRAL INDEX KEY: 0001186476
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33642
FILM NUMBER: 24899467
MAIL ADDRESS:
STREET 1: 1046 MIDDLEBROOK WAY
CITY: KENESAW
STATE: GA
ZIP: 30144
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MASIMO CORP
CENTRAL INDEX KEY: 0000937556
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 330368882
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1230
BUSINESS ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-297-7000
MAIL ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wk-form4_1714522261.xml
FORM 4
X0508
4
2024-04-26
0
0000937556
MASIMO CORP
MASI
0001186476
REYNOLDS CRAIG B
C/O MASIMO CORPORATION
52 DISCOVERY
IRVINE
CA
92618
1
0
0
0
1
Common Stock
2024-04-26
4
M
0
40000
23.04
A
47406
D
Common Stock
2024-04-26
4
S
0
40000
136.1654
D
7406
D
Non-Qualified Stock Option (Right to Buy)
23.04
2024-04-26
4
M
0
40000
0
D
2015-05-05
2024-05-05
Common Stock
40000
10000
D
The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of May 17, 2023, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $135.46 per share to a high of $137.81 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on May 5, 2014 and is exercisable as the option vests. This option vested over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
/s/ Micah W. Young, Attorney-In-Fact
2024-04-30